{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Finvestigating-hlh.simplecast.com%2Fepisodes%2Fmonitoring-treatment-response-Z5mqG9p9","width":444,"version":"1.0","type":"rich","title":"Monitoring Treatment Response","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/28a945fd-e1b5-4c16-b0ea-459c23b33a88/6d988ca5-2e09-4b1e-9526-a4c6be57ce4b/podcast-album-cover-for-amazelabs-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/ead8c41a-64b5-4ade-9b9f-25cec5fa57ba\" height=\"200\" width=\"100%\" title=\"Monitoring Treatment Response\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Kari Magee speaks with Dr Bethany Verkamp to discuss her research on evaluating treatment response to etoposide-based treatment in patients with hemophagocytic lymphohistiocytosis (HLH)."}